Cannabidiol Inhibits SARS-CoV-2 Replication & Promotes The Host Innate Immune Response

Cannabidiol from the cannabis plant has potential to prevent and inhibit SARS-CoV-2 infection Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for coronavirus disease 2019 (COVID-19), a pandemic that has overtaken the world during the past year. SARS-CoV-2, related to severe acute respiratory syndrome-related coronavirus (SARS-CoV), is the seventh species of coronavirus known to …

NEWS High-CBD Cannabis Extracts Could Provide COVID-19 Treatment

Cannabidiol’s (CBD) anti-inflammatory properties could be harnessed to treat or prevent COVID-19, according to a new study. Researchers have reported that Cannabis sativa, especially extracts high in the anti-inflammatory cannabinoid cannabidiol (CBD), has been found to alter gene expression and inflammation and harbour anti-cancer and anti-inflammatory properties. The Canadian researchers, from a range of institutions including …

CBD Has Potential To Decrease Post COVID Vaccine Side Effects By Anecdotal Medical Evidence

Side effects occur after COVID vaccinations and are more likely with the second dose of COVID vaccination as compared to the first vaccination according to US Food and Drug Administration (US FDA). Both Pfizer-BioNTech and Moderna coronavirus vaccines have caused side effects post-vaccination.  Muscle and joint pain are common symptoms associated with fever, chills, swelling …

The Potential Of Cannabidiol In The COVID-19 Pandemic

Identifying drugs effective in the new coronavirus disease 2019 (COVID-19) is crucial, pending a vaccine against SARS-CoV2. We suggest the hypothesis that cannabidiol (CBD), a non-psychotropic phytocannabinoid, has the potential to limit the severity and progression of the disease for several reasons:- (a) High-cannabidiol Cannabis sativa extracts are able to down-regulate the expression of the …